A THF solution of 1-azabicyclo[1.1.0]butane(2), obtained from 2,3dibromopropylamine hydrobromide (1), was treated with HCl-EtOH, 48% HBr, ClCO 2 Et, Ts 2 O, HCO 2 H -2.7N HCl-MeOH, or Ac 2 O -3N HCl to give the corresponding 3-monosubstituted and 1,3-disubstituted azetidine derivatives (3-7) .Similar treatment of 2 with AcSH afforded 1-acetyl-3-acetylthioazetidine (8), which was converted to 1-(1,3-thiazolidin-2-yl)azetidine-3-thiol hydrochloride (10).The compound (2) and various bromides were heated to furnish 3-bromoazetidine derivatives (12b,c,e,f) and/or N,N-disubstituted 2,3-dibromopropylamines (13a,c-f).The reaction of 2 with benzoyl peroxide or N-bromosuccinimide gave each corresponding 1,3-disubustituted azetidine derivative (14 or 15).1-Azabicyclo[1.1.0]butane(2) has proved to be the unique molecule bearing the highly strained bicyclic structure 1 and is synthetically useful for the preparation of 3-monosubstituted or 1,3-disubstituted azetidines. 2,3Recently, we have disclosed an efficient synthetic method of 2 starting from 2,3-dibromopropylamine hydrobromide (1) and its application to the syntheses of some 3-subustituted † Dedicated to Prof. James P. Kutney on the occasion of his 70th birthday.
No takes yet. Share an insight, caveat, or question.
Nagao et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: